CONSULTANT CONNECTION FOR EARLY PHASE DEVELOPMENT SOLUTIONS |
Streamline your client’s asset development with a cohesive approach to outsourcing in this issue of Consultant Connection. |
The Consultant Connection Library Did you find this information helpful? Access more topics: |
Getting Beyond the Transactional Drug Development Approach |
The venture capital model of funding drug development is probably familiar to many of your clients. As companies raise funds they often perform an initial study or small series of studies and then continue as more funding is acquired – potentially with various outsourcing vendors. This transactional, study-by-study approach may seem like their only option; however, it can be extremely costly and time-intensive resulting in:
Furthermore, today’s marketplace is more competitive and development partners seeking licensing or co-development agreements are requiring regulatory approval, Phase I and preliminary proof of concept data before considering novel molecules. The desired target milestone is to progress quickly through the IND/CTA and first in human (FIH) trial. |
Your Consultant Connectors |
Have a question about a Covance solution for your client? Lecia Johnson and her team are available to help you succeed. Ask a Question > |
Continuity for Your Client’s Drug Development Journey |
Help your clients benefit from a more efficient and cost effective way to manage the drug development process and maximize their asset’s value. Check out our Early Phase Development Solutions – a unique programmatic outsourcing model that provides continuity for the program while adding value to the asset:
Now, you have a new way to enhance your client’s competitiveness – with a strategy that’s unique for their asset and enables them to achieve success. Interested in learning more? Contact me about Early Phase Development Solutions by phone or email. |